Skip to Content
U.S. National Institutes of Health

NCI R21 and R33 Grants Awarded in FY2001 in Response to PAR-99-100, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award (R21/R33)

(PAR-99-100 is no longer an active program announcement. It has been superseded by PAR-01-104, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award.)

Would you like more information?

Abstracts of these funded grants are entered in the CRISP (Computer Retrieval of Information on Scientific Projects) database of federally funded biomedical research projects at http://crisp.cit.nih.gov/. This searchable database can be used to retrieve abstracts by grant number, principal investigator or other search terms. It also contains abstracts for grants funded in earlier fiscal years.

Grant A Bitter
DNA Mismatch Repair Functional Genetic Tests
Bittech, Inc., Agoura Hills, CA

Mark S Chee
Random Arrays for Gene Expression Profiling
Illumina, Inc., San Diego, CA

Sadanand Gite
Novel Technology for the Analysis of Gene Expression
Ambergen, Inc., Boston, MA

Paul H Johnson
Whole Genome Methylation Assay
EpigenX Pharmaceuticals, Santa Barbara, CA

Alexander A Kogon
Selection of the Best Ligands from Combinatorial Library
Biolinx, LLC, Hagerstown, MD

Steven P Piccoli
Rolling Circle Amplification Analysis of Cervical Cells
Molecular Staging, Inc., New Haven, CT

Chandra Rao
Analysis of Circulating Cancer Cells Early in Disease
Immunicon Corporation, Huntingdon Valley, PA

Shanxiang Shen
Microcantilever Array Device for Protein Profiling
Protiveris, Inc., Rockville, MD

Roberta A Sulk
One Step H. pylori Test--Screening and Individual Assays
CC Technology, Inc., Laramie, WY

Pen-Cheng Wang
2-D Microfluidic Gene Scanner
Calibrant Biosystems, Bethesda, MD

Jiwu Wang
Innovative RNA Profiling in Cancer Cells
Allele Biotech and Pharmaceuticals, San Diego, CA

Catherine E Willett
Assay for Identifying Angiogenic Drug Targets
Phylonix Pharmaceuticals, Inc., Cambridge, MA

John S Condeelis
Novel Imaging Methods for Gene Discovery in Cancer
Yeshiva University, New York, NY

Gregory W Faris
Upconverting Chelates for Cancer Detection and Diagnosis
SRI International, Menlo Park, CA

Daniel L Farkas
Cancer Molecule Analysis by AOTF Multispectral Imaging
University of Pittsburgh at Pittsburgh, Pittsburgh, PA

Maxim Frank-Kamenetskii
Studies of Hematologic Malignancies by PNA Technology
Boston University, Boston, MA

Jacques R Fresco
Fluorescent TISH Probes for Cancer Revelant Sequences
Princeton University, Princeton, NJ

Baochuan Guo
MALDI TOF Technology for Molecular Analysis of Cancer
Cleveland State University, Cleveland, OH

Kit S Lam
Peptide Microarray for Cancer Cell Surface Receptors
University of California Davis, Davis, CA

Charles M Lieber
Carbon Nanotube Probes for Direct DNA Sequence Analysis
Harvard University, Cambridge, MA

Branimir I Sikic
Gene Expression Profiling of Unknown Primary Cancers
Stanford University, Stanford, CA

Paul M Watt
Mechanisms of Genomic Instability in Cancer
TVW Telethon Institute-Child Health Res, Subiaco, Australia

Fumiichiro Yamamoto
Technology to Detect Genome-Wide DNA Methylation Changes
Burnham Institute, La Jolla, CA